compounded semaglutide ending Hims? Hers? It's Novo Nordisk's Market Now Semaglutide for weight loss |

Most GLP-1s are taken by injection, which can lead to irritation or pain at the injection site

With over 138 million people in the US affected by obesity and increasing demand for effective treatments, the market is witnessing unprecedented expansion

This guide breaks down every dose of both compounds, maps them against each other week by week, and shows you exactly what the clinical trial data says about outcomes at each level

Risk of Hypoglycemia (Low Blood Sugar) This is especially concerning for patients with diabetes or those who drink on an empty stomach

In contrast, pens for long-acting insulin, used once or twice daily, have fewer portability requirements, although similar devices are often used for both